Analysts Set Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Target Price at $12.75
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Free Report) has earned a consensus recommendation of “Hold” from the seven brokerages that are currently covering the stock, MarketBeat.com reports. Four research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1 year price target among […]
More Stories
Nuveen Asset Management LLC Trims Holdings in National Fuel Gas (NYSE:NFG)
Nuveen Asset Management LLC lessened its holdings in shares of National Fuel Gas (NYSE:NFG – Free Report) by 10.4% during...
79,507 Shares in Informatica Inc. (NYSE:INFA) Bought by Squarepoint Ops LLC
Squarepoint Ops LLC bought a new position in shares of Informatica Inc. (NYSE:INFA – Free Report) during the fourth quarter,...
Amazon.com, Inc. (NASDAQ:AMZN) Stock Position Increased by Quadcap Wealth Management LLC
Quadcap Wealth Management LLC grew its stake in shares of Amazon.com, Inc. (NASDAQ:AMZN) by 3.2% during the fourth quarter, according...
Main Management ETF Advisors LLC Sells 3,904 Shares of NVIDIA Co. (NASDAQ:NVDA)
Main Management ETF Advisors LLC reduced its holdings in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) by 8.2% during...
Nuveen Asset Management LLC Increases Holdings in Sonic Automotive, Inc. (NYSE:SAH)
Nuveen Asset Management LLC grew its holdings in Sonic Automotive, Inc. (NYSE:SAH – Free Report) by 1.1% during the 4th...
Squarepoint Ops LLC Has $2.23 Million Stake in Alignment Healthcare, Inc. (NASDAQ:ALHC)
Squarepoint Ops LLC increased its holdings in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC – Free Report) by 414.6% in the...